Cargando…

Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies

INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Downen, Julie, Jaeger, Cassie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011893/
https://www.ncbi.nlm.nih.gov/pubmed/31986120
http://dx.doi.org/10.1136/bmjoq-2019-000804
_version_ 1783496148639547392
author Downen, Julie
Jaeger, Cassie
author_facet Downen, Julie
Jaeger, Cassie
author_sort Downen, Julie
collection PubMed
description INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the project was to reduce the percent of missed opportunities for intravenous to oral conversion for applicable medications. METHODS: A pharmacy-driven intravenous to oral policy and procedure was implemented. To identify potential opportunities, a patient worklist of applicable intravenous to oral medications was created for pharmacy review in real time. An intravenous to oral conversion order was implemented in the computerised provider order entry. ‘Convert to oral’ was added as an option in the electronic medication request and highlighted reminders were added to the electronic medication administration record for eligible medications. RESULTS: After improvements, the missed opportunity rate for intravenous to oral conversion decreased from 37% (19/51) to 21% (24/113) (p=0.04, two-proportion test), a 43% improvement. The trend in intravenous to oral conversion rate increased from 76% (39/51) to 85% (171/201) and severity adjusted length of stay was reduced from 8.1 days to 6.4 days post improvements (p<0.001, t-test).
format Online
Article
Text
id pubmed-7011893
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70118932020-02-25 Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies Downen, Julie Jaeger, Cassie BMJ Open Qual Quality Improvement Report INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the project was to reduce the percent of missed opportunities for intravenous to oral conversion for applicable medications. METHODS: A pharmacy-driven intravenous to oral policy and procedure was implemented. To identify potential opportunities, a patient worklist of applicable intravenous to oral medications was created for pharmacy review in real time. An intravenous to oral conversion order was implemented in the computerised provider order entry. ‘Convert to oral’ was added as an option in the electronic medication request and highlighted reminders were added to the electronic medication administration record for eligible medications. RESULTS: After improvements, the missed opportunity rate for intravenous to oral conversion decreased from 37% (19/51) to 21% (24/113) (p=0.04, two-proportion test), a 43% improvement. The trend in intravenous to oral conversion rate increased from 76% (39/51) to 85% (171/201) and severity adjusted length of stay was reduced from 8.1 days to 6.4 days post improvements (p<0.001, t-test). BMJ Publishing Group 2020-01-20 /pmc/articles/PMC7011893/ /pubmed/31986120 http://dx.doi.org/10.1136/bmjoq-2019-000804 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Quality Improvement Report
Downen, Julie
Jaeger, Cassie
Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title_full Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title_fullStr Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title_full_unstemmed Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title_short Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
title_sort quality improvement of intravenous to oral medication conversion using lean six sigma methodologies
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011893/
https://www.ncbi.nlm.nih.gov/pubmed/31986120
http://dx.doi.org/10.1136/bmjoq-2019-000804
work_keys_str_mv AT downenjulie qualityimprovementofintravenoustooralmedicationconversionusingleansixsigmamethodologies
AT jaegercassie qualityimprovementofintravenoustooralmedicationconversionusingleansixsigmamethodologies